While WNBA stars are paid much less than their NBA counterparts, they have engaged in impactful philanthropy by using their dollars and their voices to advocate for causes that matter to them. Here’s a quick rundown.
Read MoreEven as philanthropic and public health organizations work to boost supplies of COVID vaccines in low-income countries, funders of COVID vaccine equity face an uphill battle.
Read MoreWe sit down with former WNBA player Clarisse Machanguana, Mozambique’s most storied basketball player. She talks about going back home to start a foundation focused on girls and youth, and why she’s back in the U.S.
Read MoreSince 1997, the Eleanor Crook Foundation has had a single mission—to eradicate global malnutrition. CEO Will Moore explains how the family foundation has evolved over three generations and how its work is ramping up.
Read MoreWith omicron looming, foundations like Ford, Rockefeller and Gates are spearheading an international funders’ alliance for vaccine equity. It’s worthy work, but why aren’t more big funders stepping up on global health equity?
Read MoreCivil war has created a humanitarian crisis in Ethiopia, killing thousands, including hundreds from starvation. A U.K.-based charity recently formed a $30 million partnership of three funders to support nutrition over five years.
Read MoreFollowing Sheldon Adelson’s death in January, Miriam Adelson controls the couple’s fortune and presumably their sizable philanthropy. We tried to get a read on where giving might be headed—nobody wanted to talk about it.
Read MoreShortly after his passing, Paul Allen’s estate made a $20 million gift to Swedish Health Services, where Allen received care during his battle with lymphoma. That gift is now funding a promising new approach to cancer treatment.
Read MoreCOVID-19 was a wake-up call to the world that we are insufficiently prepared to identify and stop emerging diseases. It’s a niche cause in philanthropy, but here are a few funders backing early warning systems.
Read MoreRarebase is a public benefit corporation that uses genomics to identify treatments for rare diseases. The firm’s unique model relies on small foundations and patient advocacy groups to acquire funds and patient data.
Read MoreJennifer Rainin is CEO of the Bay Area-based Rainin Foundation, a funder to watch that supports early ed, arts and medical research. We talked to the artist and former teacher about her foundation and career in philanthropy.
Read MoreJeff Skoll was one of only a handful of philanthropists backing pandemic prevention before COVID-19. That helped the Skoll Foundation hit the ground running on a global response last year, but vastly more resources are needed.
Read MoreThe Howard Hughes Medical Institute awards one the most sought-after paychecks in the biomedical research field: $9 million over seven years, no strings attached. It’s spending $300 million on the latest round.
Read MoreThe world is a different place than it was the last time Haiti suffered a major earthquake, with the pandemic and other disasters taking up donor attention. Who has stayed the course, and which new players are coming to Haiti’s aid?
Read MoreThe CDC Foundation's recent $30 million round of grants to 150 community-based organizations across the nation seeks to drive vaccine acceptance and access in historically underserved communities.
Read MoreThe Delta variant surge has underscored the urgent need for higher vaccination rates in the U.S. Across the country, foundations are working with governments and community groups to overcome vaccine hesitancy and inequities.
Read MoreThree years ago, the Foundation Fighting Blindness launched a venture philanthropy arm to invest in biotech companies and bring treatments to market. Ten companies in, the effort is going strong.
Read MoreThe pandemic revealed deadly gaps in our capacity to test for disease, especially in developing parts of the world. In an innovative impact investing deal, philanthropies are turning a diagnostics company into a social enterprise.
Read MoreThe development of new drugs and other medical treatments can take many years and billions of dollars. Cures Within Reach aims to find new uses for already-approved therapies to ease suffering and save lives faster.
Read MoreWith the coronavirus pandemic still a global emergency, the Rockefeller Foundation committed $20 million to help knit together an international network that will share genomic and other data to prevent future pandemics.
Read More
Whether you raise money or give it away,
Inside Philanthropy is an essential resource.
